Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000808420 | SCV000948529 | uncertain significance | Alstrom syndrome | 2018-11-21 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with tyrosine at codon 1809 of the ALMS1 protein (p.His1809Tyr). The histidine residue is moderately conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with ALMS1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000808420 | SCV002080531 | uncertain significance | Alstrom syndrome | 2020-09-21 | no assertion criteria provided | clinical testing |